|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Veterans Affairs Medical Center and 2 Department of Physiology and Biophysics, University at Buffalo, Buffalo, New York 14215
We investigated prostanoid biogenesis by human colonic fibroblasts (CCD-18Co cells and nine primary fibroblast cultures) exposed to a primary (cholic, CA) or a secondary (deoxycholic, DCA) bile acid. Basal PGE2 levels in CCD-18Co cultures and fibroblast strains initiated from normal and adenocarcinomatous colon, respectively, were 1.7 ± 0.3, 4.0 ± 2.0, and 15.0 ± 4.8 ng/mg protein. Peak levels 24 h after exposure to DCA (300 µM) rose, respectively, seven-, six- and sevenfold, but CA elicited no such responses. Increases in PGE2 synthesis were preceded by sequential increases in PGH synthase-2 mRNA and protein expression and were fully prevented by a nonselective (indomethacin) or a selective (celecoxib) nonsteroidal anti-inflammatory drug. DCA, but not CA, caused abrupt, transient increases in fibroblast intracellular Ca2+ concentration ([Ca2+]i) ~1 min after exposure. Increased [Ca2+]i was required for DCA-mediated induction of PGE2 synthesis, and protein kinase C was a further essential component of this signaling pathway. Colonic fibroblasts may be a major target for prostanoid biogenesis induced by fecal bile acids and, potentially, other noxious actions of these agents.
colorectal neoplasms; feces; mesenchymal cells; prostaglandin H synthases
This article has been cited by other articles:
![]() |
J. M. Ridlon, D.-J. Kang, and P. B. Hylemon Bile salt biotransformations by human intestinal bacteria J. Lipid Res., February 1, 2006; 47(2): 241 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. C. Bijvelds, H. Jorna, H. J. Verkade, A. G. M. Bot, F. Hofmann, L. B. Agellon, M. Sinaasappel, and H. R. de Jonge Activation of CFTR by ASBT-mediated bile salt absorption Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G870 - G879. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Adegboyega, O. Ololade, J. Saada, R. Mifflin, J. F. Di Mari, and D. W. Powell Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas Clin. Cancer Res., September 1, 2004; 10(17): 5870 - 5879. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Hess, M. F. Krutzsch, J. Guillen, H-H. S. Chow, J. Einspahr, A.K. Batta, G. Salen, M. E. Reid, D. L. Earnest, and D. S. Alberts Results of a Phase I Multiple-Dose Clinical Study of Ursodeoxycholic Acid Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chitapanarux, S. L. Chen, H. Lee, A. C. Melton, and H. F. Yee Jr. C-type natriuretic peptide induces human colonic myofibroblast relaxation Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G31 - G36. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, P. Hua, and P. Lance Cyclooxygenase-2 Expression and Prostanoid Biogenesis Reflect Clinical Phenotype in Human Colorectal Fibroblast Strains Cancer Res., January 15, 2003; 63(2): 522 - 526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |